A U.S. Federal Court has reportedly ruled in favor of Astellas Pharma in a patent litigation case over generic Myrbetriq, according to a livemint.com report. The ruling blocks Lupin and Zydus Life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results